 |
DHA-paclitaxel |
|---|---|
| Trade Name | Taxoprexin |
| Orphan Indication | Adenocarcinoma of the stomach or lower esophagus |
| USA Market Approval | USA |
| USA Designation Date | 2003-05-01 00:00:00 |
| Sponsor | Luitpold Pharmaceuticals, Inc.;One Luitpold Drive, P. O. Box 9001;Shirley, New York, 11967 |
